Trxade Group, Inc. (NASDAQ:MEDS) is a technology oriented company providing efficient integrated pharmaceutical and medical services to pharmacies and consumers. It combines a web-based purchasing platform for supply chain transactions between independent pharmacies, drug distributors and manufacturers. The robust e-commerce technology platform delivers buyer/seller pricing algorithms, product availability and data analytics features. The Company additionally operates a specialty pharmacy, warehouse and prescription delivery services for consumers throughout the US utilizing its proprietary Delivmeds mobile application (delivmeds.com), and multi specialty telemedicine portal (bonumhealth.com) that enables efficient home delivery of patient care and medication.
TRxADE Group, Inc. trades under the Nasdaq ticker symbol MEDS
CUSIP number: 89846A207
The company’s common stock can be purchased through any registered broker-dealer.
The company does not declare dividends on shares of its common stock at this time.
As of February 27th 2020, there were 7,500,000 shares of common stock issued and outstanding.
The company does not have a direct stock purchase plan at this time.
New York, New York
Action Stock Transfer Corp.
2469 E Fort Union Blvd. Suite 214
Salt Lake City UT 84121
9801 Westheimer Road Suite 100
Houston, TX, 77042
Tel: (713) 343-4286
Fax: (949) 428-0280
TRxADE Group, Inc.
3840 Land O’ Lakes Blvd
Land O Lakes, FL 34639
Tel: (800) 261-0281
Fax: (800) 265-6932